Pancreatic cancer screening has advanced significantly in recent years. There are now research-based guidelines on screening ...

EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first ...

Precursor lesions of pancreatic cancer are very difficult to characterize with magnetic resonance imaging (MRI). But now, in a new study, researchers led by Noam Shemesh and Carlos Bilreiro ...

2025 — An enzyme called MICAL2 promotes tumor growth and metastasis in the most common form of pancreatic cancer, according to a new ... Advanced Imaging Uncovers Hidden Metastases in High-Risk ...

Northwestern Medicine surgical oncologist Dr. David Bentrem met with Timchak, and they agreed a Whipple procedure—in which the head of the pancreas, the first part of the mall intestine, the ...

Pancreatic adenocarcinoma is one of the leading causes of cancer death in the West ... or non-resectable at presentation. Therefore, imaging plays a crucial role in the management of this disease.

On December 20, 2024, the FDA granted accelerated approval to the combination of encorafenib (Braftovi), cetuximab (Erbitux), ...

Precursor lesions of pancreatic cancer are very difficult to characterise with magnetic resonance imaging (MRI). But now, in a new study, researchers led by Noam Shemesh and Carlos Bilreiro ...

A new molecular imaging agent can accurately identify a crucial biomarker found among many different types of cancer.